Switching from Gilenya to Lemtrada could trigger MS activity
According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
Switching from Gilenya to Lemtrada could trigger MS activity
Switching from Gilenya to Lemtrada could trigger MS activity
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1212 Views
-
Last post by frodo
-
- 0 Replies
- 1025 Views
-
Last post by frodo
-
- 0 Replies
- 1080 Views
-
Last post by NHE
-
- 1 Replies
- 1563 Views
-
Last post by ElliotB
-
- 5 Replies
- 14202 Views
-
Last post by gibbledygook